% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Raut:157469,
author = {J. Raut$^*$ and Z. Guan$^*$ and P. Schrotz-King$^*$ and H.
Brenner$^*$},
title = {{F}ecal {DNA} methylation markers for detecting stages of
colorectal cancer and its precursors: a systematic review.},
journal = {Clinical epigenetics},
volume = {12},
number = {1},
issn = {1868-7083},
address = {[S.l.]},
publisher = {BioMed Central},
reportid = {DKFZ-2020-01648},
pages = {122},
year = {2020},
note = {#EA:C120#LA:C070},
abstract = {DNA methylation biomarkers in stool may have applications
in early colorectal cancer (CRC) detection; however, their
association with stages of CRC carcinogenesis or their
performance in detecting various stages is unclear. We aimed
to systematically review the evidence for DNA methylation
markers in stool for risk stratification or detection of
specific CRC stages, as well as precursors of CRC.We
conducted a systematic search in line with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
guidelines. We searched PubMed and ISI Web of Knowledge to
identify relevant studies published until 14th January 2020.
Two reviewers independently extracted data on study
population characteristics, candidate genes, methylation
measurement methods, odds ratios (ORs), overall and
stage-specific sensitivities, specificities, areas under the
receiver operating characteristics curve, and p-values for
statistical significance for OR and for association of
methylation levels with stage.Twenty-seven studies that
reported stage-specific associations or performances of
fecal DNA methylation markers for detecting colorectal
neoplasms were identified. All studies used
methylation-specific polymerase chain reaction for assessing
methylation levels in the promoter or exon 1 regions of
targeted genes. However, most studies were underpowered and
limited by their case-control design. Furthermore, the
stage-specific associations or sensitivities were validated
for two markers (hypermethylation of GATA4 and VIM)
only.Methylation markers in stool may be useful for
detection of CRC precursors or CRC staging, but promising
candidate markers need to be validated in longitudinal
studies on large screening populations, performing
epigenome-wide analyses. Identification of stage-specific
DNA methylation biomarkers in stool could boost current
strategies towards early detection and enable different
approaches to precision medicine for CRC.},
subtyp = {Review Article},
cin = {C120 / C070 / HD01},
ddc = {610},
cid = {I:(DE-He78)C120-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32778176},
doi = {10.1186/s13148-020-00904-7},
url = {https://inrepo02.dkfz.de/record/157469},
}